The expression of PD-L1 in patients with castrate prostate cancer treated with enzalutamide
{{output}}
Purpose: The purpose of our retrospectively study was to evaluate the PD-L1 expression in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide. ... ...
